Sanibel Captiva Trust Company’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$751K Sell
10,719
-700
-6% -$36.2K 0.02% 283
2026
Q1
$580K Hold
11,419
0.02% 289
2025
Q4
$337K Buy
+11,419
New +$310K 0.01% 346

Other funds holding MRNA

Sanibel Captiva Trust Company's MRNA Position: Q2 2026 in Review

Sanibel Captiva Trust Company reduced its Moderna (MRNA) stake by 6.1% in Q2 2026, selling an estimated $36.2K and leaving 10,719 shares worth $751K. The position accounts for 0.02% of the portfolio, ranked #283.

Sanibel Captiva Trust Company first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Sanibel Captiva Trust Company held 10,719 shares of Moderna worth $751K as of Q2 2026.
  • Sanibel Captiva Trust Company sold 700 Moderna shares in Q2 2026, an estimated $36.2K.
  • Moderna made up 0.02% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #283 holding.
  • Sanibel Captiva Trust Company first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.